Mblue Labs, the biotech company behind the innovative Bluelene skincare brand, has recently been granted a U.S. Patent for their groundbreaking discovery of Methylene Blue as a multifunctional UV blocking agent. This patent signifies a significant milestone in the company’s journey towards redefining sun care with smart, effective, and planet-safe science. Supported by research dating back to 2020, Methylene Blue has been proven to offer broad-spectrum UV irradiation protection, neutralize Free Radicals, and repair UV-induced DNA damages—all while being safe for coral reefs. Dr.
Kan Cao, the Founder and Chief Scientific Officer of Mblue Labs, emphasizes that their formula goes beyond surface protection to address the molecular triggers of skin health and aging. With the launch of ‘Bluevado SunFix’, their anti-aging sunscreen combining physical filters and an optimized dosage of Methylene Blue, Mblue Labs has garnered a loyal following of consumers seeking sustainable, science-based suncare products with exceptional efficacy. This patent further solidifies Methylene Blue’s position as a leader in science-based skincare and environmentally responsible innovation, as the company actively pursues regulatory pathways to expand access to its skin- and planet-friendly benefits.
Read more from finance.yahoo.com